News & Events

christian_beck
24.09.2014

Change in sales management at DYCONEX

DYCONEX is making a new appointment for the position of Director Sales starting October 1, 2014. Following a familiarization phase, Christian Beck will assume the duties of Stefan Hilfiker, who has decided to take an 11-month sabbatical leave.

MST at Neurotech Leaders Forum 2014

neurotech_leaders_forum_108px

Neurotechnology Industry 
October 20 - 21, 2014
Doubletree San Francisco Airport North, San Francisco, CA, USA

MST at COMPAMED 2014

COMPAMED

High tech solutions for medical technology
November 12 - 14, 2014
Messe Düsseldorf, Germany
Hall 8a, Booth# 8aC03

MST at Advanced Technology Workshop on Microelectronics 2014, France

IMAPS
Workshop on Microelectronics, Systems & Packaging for Medical Applications
December 9 - 11, 2014
Metropole Congress Hotel, Lyon, France


DYCONEX LIQUID CRYSTAL POLYMER (LCP) SUBSTRATE PROVES CYTOTOXICITY CONFORMITY ACCORDING TO ISO 10993-5

Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.

Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.